NeoGenomics, Inc. Impairment of Intangible Assets, Finite-lived
NeoGenomics, Inc. (NEO) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2019-02-26
- NeoGenomics, Inc. impairment of intangible assets, finite-lived for fiscal 2018 was $0.00.
- NeoGenomics, Inc. impairment of intangible assets, finite-lived for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- NeoGenomics, Inc. impairment of intangible assets, finite-lived for fiscal 2016 was $3.46M.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-26 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | $253.00K 10-K · filed 2018-03-13 |
| 2016-12-31 | $3.46M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |